Blotter

In State of the Union, Trump misrepresents administration’s
support for medical research

Benjamin Corb
Feb. 5, 2020

President Donald Trump used a portion of last night’s State of the Union address to whitewash his administration’s attempts to undermine and defund science. Roughly three-quarters of the way through the speech, he said:

Read the ASBMB's response

“President Donald Trump took a revisionist look back at his administration’s support for biomedical research that leads to life-saving breakthroughs." Read more.

“We have launched ambitious new initiatives to substantially improve care for Americans with kidney disease, Alzheimer's, and those struggling with mental health challenges.  And because the Congress funded my request, we are pursuing new cures for childhood cancer, and we will eradicate the AIDS epidemic in America by the end of the decade.”

Specifically attention-grabbing to me was “And because Congress funded my request.”

Let’s be very clear about the president, his record on funding biomedical research, and what the status of funding is. 

Today, the National Institutes of Health operates at an annual budget of $40.2 billion.  That is the fiscal year 2020 enacted level, approved by Congress and signed into law by Trump in late 2019.  The $40.2 billion marked a $2.6 billion (6.6%) increase over the fiscal 2019 enacted spending level.  

Trump’s budget request for fiscal year 2020 for the NIH was $34.4 billion.  This number represented a $4.9 billion (12.6%) cut from fiscal 2019 enacted levels.  With the lone exception of buildings and facilities, under Trump’s fiscal 2020 budget request, all institutes, centers and budget activity would have been cut.

It was Congress, with strong bipartisan support, that rejected Trump’s budget request and funded the NIH at a level 22% above the administration’s budget request for fiscal 2020. 

This is the story and the legacy of the Trump administration as it relates to funding for medical research that leads to cures and breakthroughs.

For fiscal 2019, Trump’s initial budget request called for a 27% cut to NIH funding — and it was followed by a supplement that reversed the cuts and requested level funding.

Trump’s first budget request in 2017 called for a 22% cut to the NIH, which would have brought NIH funding to its lowest level since 2002.  Once again, these cuts were rejected by a Congress supportive of investments in medical research.

Before last night’s State of the Union, I wrote about how Trump has largely left science out of his previous addresses to Congress.  In his previous speeches, while he had spoken more than 16,000 words, he mentioned science, research and cures only six times. I argued that the lack of rhetoric from the president supporting science in his speeches matched the lack of support science has seen from this administration.

One section of one speech does not make the president a champion of biomedical research or innovation.  Unless and until we see demonstrated changes in the administration’s attitude toward investing in life-saving research, we are left with few options other than seeing the president’s comments as opportunistic and an attempt to gloss over just how uninterested he is in supporting American innovation and the NIH.

Benjamin Corb

Benjamin Corb is director of public affairs at ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Opinions

Opinions highlights or most popular articles

Lessons from plants: A changing environment
Books

Lessons from plants: A changing environment

April 7, 2021

Beronda Montgomery writes about plants adapt to environmental conditions in this excerpt from her new book.

Retracting publications doesn’t stop them from influencing science
News

Retracting publications doesn’t stop them from influencing science

March 28, 2021

The whole purpose of retraction — marking research as poor quality or even as fraudulent — frequently doesn't seem to affect how those papers are read and cited.

How can we recognize and reward innovation in teaching?
Essay

How can we recognize and reward innovation in teaching?

March 25, 2021

“Publications that describe curricular or pedagogical innovations are rarely cited, and their authors get little feedback about their impact.”

Life after one year of COVID-19
Member News

Life after one year of COVID-19

March 25, 2021

In March 2020, we asked ASBMB members how the pandemic is affecting them personally and professionally. We recently asked them how it has changed there lives, one year later. Here are their dispatches.

One year later
Editor's Note

One year later

March 19, 2021

Since mid-March 2020, the way we do everything has been shifted by the COVID-19 pandemic, layered with all the ordinary changes of work and life and coping.

The challenges of antiviral treatments
News

The challenges of antiviral treatments

March 13, 2021

Antibiotics abound, but virus-fighting drugs are harder to come by, and Covid-19 amply shows how much we need them. Fortunately, scientists are getting better at making and finding them.